Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventional

Telehealth Intervention to Address Distress and Financial Toxicity in the Care Partners of Patients Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

NCT ID: NCT06709404Sponsor: Wake Forest University Health SciencesLast updated: 2026-04-13

Summary

This clinical trial assesses whether resource identification for primary caregivers can affect financial stress, quality of life, depression, and the general belief in the ability to cope with daily life. Caregivers of patients receiving cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS+HIPEC) demonstrate that they endure high depressive symptom burdens and financial distress. Further, they experience symptom trajectories that differ from those of patients. In short, they require differential timing of supportive interventions. This study aims to reduce financial toxicity and distress levels and to increase self-efficacy, satisfaction and engagement with care. Information gathered from this study may help researchers determine whether telehealth interventions for caregivers may increase awareness of recommended resources that could be beneficial during caregivers journey.

Detailed description

PRIMARY OBJECTIVE: I. To assess the feasibility of a telehealth navigation intervention for CS+HIPEC caregivers. SECONDARY OBJECTIVES: I. To assess the efficacy of the intervention on financial distress and depression in intervention and standard of care caregivers. II. To compare financial distress in intervention caregivers as compared to standard of care caregivers. III. To compare satisfaction with care experiences in intervention caregivers as compared to standard of care caregivers. IV. To compare self-efficacy for navigating treatment-related costs in intervention caregivers as compared to standard of care participants. V. To compare self-reported community resource use among intervention and standard of care caregivers. VI. To compare the quality of life over time in intervention caregivers as compared to standard of care caregivers. VII. To compare social support over time in intervention caregivers as compared to standard of care caregivers. VIII. To compare treatment satisfaction for intervention caregivers as compared to standard of care caregivers. OUTLINE: Participants are randomized to 1 of 2 groups. GROUP I: Participants receive telehealth navigation intervention which may consist of referral to specific resources for caregiving experience over 1 hour 1-4 weeks prior to patient's surgery. GROUP II: Participants receive standard caregiving experience on study. After completion of study intervention, participants are followed up at 3, 6, 12, and 24 months.

Arms & interventions

  • OtherTelemedicine

    Receive telehealth navigation intervention

  • OtherSurvey administration

    Ancillary studies

  • OtherElectronic health record review

    Ancillary studies

  • OtherBest Practice

    Receive standard caregiving experience

Outcome measures

Primary

  • Number of Caregivers to Complete Center for Epidemiologic Studies-Depression Scale (CES-D) - (Feasibility)

    Feasibility will be measured by the number of caregivers who complete the Center for Epidemiologic Studies-Depression Scale (CES-D). The 95% confidence interval for the observed rates will be calculated.

    Time frame: At 1 and 2 years

Secondary

  • Depression - Center for Epidemiologic Studies-Depression Scale (CES-D) - Efficacy

    Time frame: Up to 2 years

  • Financial distress - Comprehensive Score for Financial Toxicity-Functional Assessment of Chronic Illness Therapy

    Time frame: Up to 2 years

  • Satisfaction with telehealth intervention - Caregiver Reflection of Intervention Form

    Time frame: Up to 2 years

  • Self-efficacy

    Time frame: Up to 2 years

  • Self-reported community resource

    Time frame: Up to 2 years

  • Caregiver quality of life - Caregiver Quality of Life Index-Cancer (CQOLC)

    Time frame: Up to 2 years

  • Social support - Medical Outcome Study Social Support Survey (MOS-SSS)

    Time frame: Up to 2 years

  • Treatment satisfaction - Family Satisfaction with End-of-Life Care (FAMCARE)

    Time frame: Up to 2 years

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: No
Inclusion Criteria * Primary caregiver of a patient scheduled to receive CS+HIPEC at Atrium Health Wake Forest Baptist Comprehensive Cancer Center * Access to a computer or smartphone and must have an email address * 18 years of age or older at the time of consent * The ability to understand and willingness to provide written informed consent * The ability to read and write English Exclusion Criteria \- Patient declines access to their medical record

Study locations (1)

Wake Forest Baptist Comprehensive Cancer Center

Winston-Salem, North Carolina, 27157

Recruiting
Katie Duckworth, PhD · Principal Investigator